Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now
Download Presentation
Video Images

PPT-Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial PowerPoint Presentation

VA Cooperative Studies Program Trial 578 ContrastAssociated Acute Kidney Injury CAAKI Common post angiography amp associated with death dialysis progressive CKD

nac aki angiography endpoint aki nac endpoint angiography trial nacl comparisons preserve pre nahco groups placebo outcomes angio prevention

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Prevention of Serious Adverse Events Fol..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial: Transcript

Show More

Related Contents

A series of randomised controlled N-of 1 trials in patients
A series of randomised controlled N-of 1 trials in patients
tatyana-admore
A series of randomised controlled N-of 1 trials in patients who have discontinued or are
A series of randomised controlled N-of 1 trials in patients who have discontinued or are
min-jolicoeur
Remote Monitoring of Adverse Events
Remote Monitoring of Adverse Events
conchita-marotz
Lessons to learn from the reporting of adverse events in RCTs published in four high impact
Lessons to learn from the reporting of adverse events in RCTs published in four high impact
phoebe-click
Adverse Events
Adverse Events
sherrill-nordquist
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
mitsue-stanley
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
lois-ondreau
SAFETY PRACTICES AND REPORTING IN CLINICAL RESEARCH
SAFETY PRACTICES AND REPORTING IN CLINICAL RESEARCH
min-jolicoeur
Did that just happen? And
Did that just happen? And
mitsue-stanley
Treatment for 12 or 24 weeks with BI201335 combined with pe
Treatment for 12 or 24 weeks with BI201335 combined with pe
lindy-dunigan
Aspirin in Cardioprevention:
Aspirin in Cardioprevention:
pamella-moone
Symptom Management of Novel Agents
Symptom Management of Novel Agents
yoshiko-marsland
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
natalia-silvester
Expedited Adverse Event
Expedited Adverse Event
pasty-toler

Copyright © 2024 DocSlides. All Rights Reserved